Presagen Email Format
Hospitals and Health CareCalifornia, United States2-10 Employees
Qubigen is a San Francisco-based venture formed through the merger of Presagen and Qubist. It combines Presagen’s Federated AI technology with Qubist’s virtual screening and AI-driven drug design capabilities to support AI-enabled drug discovery. The company seeks to build the largest global federated proprietary dataset and computational toolbox for AI-guided drug design. Its primary customers are biopharma, biotechnology, and life sciences researchers seeking new therapeutic candidates. In May 2026, Qubigen announced a collaboration with the Dana-Farber Cancer Institute to explore novel kidney cancer research using its AI platform. The organization operates with a small team focused on research collaborations.